New study finds that Polish men with prostate cancer have lower vitamin D levels than men with benign prostatic hyperplasia

Posted on: April 27, 2015   by  Vitamin D Council

img

New research has discovered that patients with prostate cancer have lower vitamin D levels compared to patients with benign prostatic hyperplasia.

Multiple studies have shown a link between vitamin D levels and prostate cancer with a study reporting that men with prostate cancer who had the lowest vitamin D levels were less likely to survive compared to men who had higher vitamin D levels.

In a recent study, researchers from Poland compared the vitamin D levels between 30 men with prostate cancer and 30 men with benign prostatic hyperplasia (BPH). BPH is a condition in which the prostate gland is enlarged and not cancerous.

The researchers wanted to determine whether low vitamin D levels were associated with an increased risk of prostate cancer. They found that the patients with prostate cancer were vitamin D deficient, with a median vitamin D status of 25.3 ng/ml; whereas patients with BPH had a median vitamin D level of 34.8 ng/ml.

The researchers concluded, “Vitamin D concentration in Polish men with prostate cancer is lower compared to patients with benign prostatic hyperplasia.”

Source

Wieczorek K. et al. “The comparison between vitamin d concentration in upper silesia patients with prostate cancer and with benign prostatic hyperplasia.” Journal of biological regulators and homeostatic agents, 2015.

Test Your Vitamin D Levels at Home!

Our in-home Vitamin D Test Kit is easy, affordable, and an accurate way to find out your Vitamin D status.

order NOW

We need your help!

We're spreading awareness on Vitamin D Deficiency
Donate NOW
Latest Articles
img
Vitamin D supplementation may provide relief for patients with atopic dermatitis

A recently published meta-analysis proves that vitamin D supplementation is a safe and effective treatment for atopic dermatitis.

Weekly Newsletter